[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607016":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":40,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":65,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Hacettepe University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cases diagnosed with scleroderma",null,"Child and adult scleroderma patients who visited the rheumatology outpatient clinic at a university hospital will complete a questionnaire.",[13],"Other: Questionnaire and functionality application for child and adult scleroderma patients",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Questionnaire and functionality application for child and adult scleroderma patients","Scales and functionality tests will be applied to cases diagnosed with scleroderma",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Orkun Tüfekçi, PT, PhD(c)","CONTACT","5319502648","orkuntf@gmail.com",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":10,"country":30,"countryCode":10,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Çankaya","Ankara","Turkey (Türkiye)",{"type":32,"coordinates":33},"Point",[34,35],32.86268,39.9179,{"lat":35,"lon":34},[38],{"name":21,"role":22,"phone":39,"phoneExt":10,"email":24},"05319502648",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Orkun Tüfekçi","Principal Investigator, PT, PhD(c)","100607016","patients-diagnosed-with-scleroderma-physical-performance-and-functionality-100607016",false,"NCT07183072","Patients Diagnosed With Scleroderma: Physical Performance and Functionality","Investigating the Relationship Between the Biopsychosocial Status of Individuals Diagnosed With Scleroderma and Their Physical Performance and Functionality","\\*For a child diagnosed with scleroderma\\*\n\nInclusion Criteria:\n\n* Cases diagnosed with scleroderma,\n* Cases aged 7-18 years will be included.\n\nExclusion Criteria:\n\n* Advanced heart\u002Flung\u002Fliver\u002Fkidney disease, neurological disease, and malignancies\n* Cases that are not willing to participate in the study will be excluded.\n* Having participated in a regular exercise program for the past 3 months\n* Individuals who are not willing to participate in the study\n\n\\*For adults diagnosed with scleroderma\\*\n\nInclusion Criteria:\n\n* Individuals diagnosed with scleroderma,\n* Individuals over the age of 18 will be included.\n\nExclusion Criteria:\n\n* Advanced heart\u002Flung\u002Fliver\u002Fkidney disease, neurological disease, and malignancies\n* Individuals who are not willing to participate in the study will be excluded.\n* Having participated in a regular exercise program for the past 3 months\n* Individuals who are not willing to participate in the study","ALL","7 Years",{"count":54,"type":55},50,"ESTIMATED","2 Weeks","OBSERVATIONAL","Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality.\n\nAdditionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.",[60,61,62,63,64],"Systemic Sclerosis (SSc)","Scleroderma","Scleroderma (Limited and Diffuse)","Scleroderma, Localized","Functionality",[66,67,68,69,70],"Juvenile scleroderma","scleroderma","systemic sclerosis","physical performance","functionality","2025-09-13",{"date":73,"type":74},"2025-09-19","ACTUAL",{"date":76,"type":74},"2025-08-04",{"date":78,"type":55},"2027-08-04",{"name":5,"class":6},1]